Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia

Published:2022-07-19 Issue:16 Volume:16 Page:2899-2919
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Ramos‐Muntada Mireia¹,Trincado Juan L.²³⁴,Blanco Joan¹,Bueno Clara²⁴⁵,Rodríguez‐Cortez Virginia C.²⁴,Bataller Alex²⁴⁶,López‐Millán Belén²⁴,Schwab Claire⁷,Ortega Margarita⁸,Velasco Pablo⁹,Blanco Maria L.¹⁰,Nomdedeu Josep¹⁰,Ramírez‐Orellana Manuel¹¹,Minguela Alfredo¹²,Fuster Jose L.¹³,Cuatrecasas Esther¹⁴,Camós Mireia¹⁵¹⁶¹⁷,Ballerini Paola¹⁸,Escherich Gabriele¹⁹,Boer Judith²⁰²¹,DenBoer Monique²⁰²¹²²,Hernández‐Rivas Jesús M.²³,Calasanz Maria J.²⁴,Cazzaniga Giovanni²⁵,Harrison Christine J.⁷,Menéndez Pablo²⁴⁵²⁶,Molina Oscar²⁴^ORCID

Affiliation:

1. Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group Universitat Autònoma de Barcelona Spain

2. Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute University of Barcelona Spain

3. CNAG‐CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Spain

4. Red Española de Terápias Avanzadas (TERAV) ISCIII Barcelona Spain

5. Centro de Investigación Biomédica en Red de Cáncer (CIBER‐ONC) ISCIII Barcelona Spain

6. Hematology Department, Hospital Clínic de Barcelona, IDIBAPS University of Barcelona Spain

7. Wolfson Childhood Cancer Research Centre Newcastle University UK

8. Hematology Service, Experimental Hematology, Vall d'Hebrón Institute of Oncology (VHIO) Vall d'Hebrón Hospital Universitari Barcelona Spain

9. Pediatric Oncology and Hematology Department Vall d'Hebrón Hospital Barcelona Spain

10. Hematology Laboratory Hospital Sant Pau Barcelona Spain

11. Hematology Diagnostic Laboratory Hospital Niño Jesús Madrid Spain

12. Immunology Service Clinic University Hospital Virgen de la Arrixaca and Instituto Murciano de Investigación Biomédica (IMIB) Murcia Spain

13. Pediatric Hematology and Oncology Department Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB) Murcia Spain

14. Hematology Laboratory Institut de Recerca Hospital Sant Joan de Déu Barcelona Spain

15. Hematology Laboratory, Hospital Sant Joan de Déu University of Barcelona Spain

16. Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group Institut de Recerca Hospital Sant Joan de Déu Barcelona Spain

17. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Instituto de Salud Carlos III Madrid Spain

18. AP‐HP, Service d'Hématologie Pédiatrique Hôpital A. Trousseau Paris France

19. Department of Pediatric Hematology and Oncology University Medical Center Hamburg Germany

20. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

21. Oncode Institute Utrecht The Netherlands

22. Department of Pediatric Oncology/Hematology Erasmus MC – Sophia Children's Hospital Rotterdam The Netherlands

23. Departamento de Hematología, Salamanca‐IBSAL Hospital Universitario de Salamanca Spain

24. CIMA Lab Diagnostics Universidad de Navarra Pamplona Spain

25. Fondazione Tettamanti Monza Italy

26. Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain

Funder

H2020 European Research Council

Fundación Española de Hematología y Hemoterapia

Fundación Científica Asociación Española Contra el Cáncer

Ministerio de Ciencia e Innovación

Blood Cancer UK

Universitat Autònoma de Barcelona

Generalitat de Catalunya

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13276

Reference49 articles.

1. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

2. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia

3. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331

4. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

5. Declining childhood and adolescent cancer mortality

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia;Leukemia;2024-03-22

2. Maternal Lifestyle and Prenatal Risk Factors for Childhood Leukemia: A Review of the Existing Evidence;Fetal Diagnosis and Therapy;2024

3. Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression;EMBO Molecular Medicine;2023-12-15

4. B-Lymphoblastic Leukemia/Lymphoma;Advances in Molecular Pathology;2023-11

5. Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2023-05-15